CEFAZOLIN SANDOZ 0.5 G

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

CEFAZOLIN AS SODIUM 500 MG/VIAL

Mevcut itibaren:

MASROUJI COMPANY LTD

ATC kodu:

J01DB04

Farmasötik formu:

POWDER FOR SOLUTION FOR INJECTION

Uygulama yolu:

I.V, I.M

Tarafından üretildi:

SANDOZ GmbH, AUSTRIA

Terapötik grubu:

CEFAZOLIN

Terapötik endikasyonlar:

Treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. Treatment Respiratory tract: Respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group A B - hemolytic streptococci. Cefazolin is effective in the eradication of streptococci from the nasopharynx. However data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. Urinary tract: Infections due to escherichia coli klebsiella species proteus mirabilis and some strains of Enterobacter and enterococci. Skin and skin structure: -hemolytic beta Infections due to Staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group A streptococci and other strains of streptococci. Biliary tract: Infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

Yetkilendirme tarihi:

2009-10-01